![[Mike Maguires avatar]](https://franklintempletonprod.widen.net/content/gbidohppgf/webp/Maguire_Michael_500x500.png){kind=avatar}
Managed Fund Since 2016
Equity
PHSYX Putnam Global Health Care Fund
- Research-intensive process. Combines deep fundamental research with technical expertise and actively monitors scientific innovation and regulatory changes to identify opportunities.
- Innovation-driven growth. Seeks to harness the steady, global demand for innovative health care solutions to pursue attractive returns regardless of economic conditions.
- Concentrated, best-ideas approach. Pursues alpha over a full market cycle by combining a bottom-up approach and disciplined risk management to build a focused portfolio of 30–50 high-conviction names.
Popular Documents
Total Net Assets
$1.49B
As of 10/31/2025 (Updated Monthly)
Overview
Fund Facts
Fund description
The fund seeks capital appreciation. Combines deep fundamental research with technical expertise and actively monitors scientific innovation and regulatory changes to identify opportunities.
- Benchmark
- MSCI World Health Care Index-NR
- Fund Inception Date
- 05/28/1982
- Dividend Frequency, if any
- Annually
- Portfolio Turnover
- 67%
Identifiers
- Ticker
- PHSYX
- Fund Number
- 1813
- CUSIP Code
- 746778505
Average Annual Total Returns As of 10/31/2025
Class Y
- -1.07%1 Year
- 7.25%3 Years
- 9.01%5 Years
- 7.90%10 Years
- 11.45%Since Inception
05/28/1982
Performance data quoted represents past performance, which does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the figures shown.
Top Sectors
As of 10/31/2025 % of Total (Updated Monthly)
Additional Fund Info
- Share Class Inception Date
- 04/04/2000
- Investment Style
- Sector
- Lipper Classification
- Global Health/Biotechnology Funds
- Morningstar Category
- Health
Manager and Commentary
About the Team
Putnam Investments
Putnam Investments has been serving clients and shareholders for over 85 years. We manage a range of equity portfolios with a focus on stock-specific opportunities. Our approach — stock-driven rather than style-driven — is designed to offer consistent outperformance, regardless of the market environment. Our portfolios are fueled by a variety of independent views and perspectives, enhanced by fundamental research and ongoing dialogue and debate. We combine this with portfolio construction that aims to reduce broader macro exposures and manage downside risk.
Putnam Investments
Latest Insights
August 14, 2025
March 19, 2025
Performance
Average Annual Total Returns
As of 10/31/2025
Selected Month October 2025
Class Y - With Sales Charge (POP) (%)
Month End
As of 10/31/2025
Class Y - Without Sales Charge (NAV) (%)
Month End
As of 10/31/2025
MSCI World Health Care Index-NR (%)
Month End
As of 10/31/2025
Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment returns will fluctuate, and investors' shares, when redeemed, may be worth more or less than the original cost. Performance would have been lower if fees had not been waived in various periods. Total returns assume the reinvestment of all distributions and the deduction of all Fund expenses. Returns with sales charge reflect a deduction of the stated maximum sales charge. Returns without sales charge would have been lower had sales charges been reflected. An investor cannot invest directly in an index, and unmanaged index returns do not reflect any fees, expenses or sales charges. Returns for periods of less than one year are not annualized.
The fund began offering Class Y shares on 4/4/2000. Returns for periods prior to 4/4/2000 are based on the fund's Class A performance, which has not been adjusted for the lower operating expenses; had it been adjusted, performance would be higher. For periods after the share class offering, performance for the specific share class is used, reflecting the applicable expenses and maximum sales charges.
Ratings 3
©2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Portfolio
Assets
As of10/31/2025 (Updated Monthly)
- Total Net Assets
- $1.49 Billion
Positions
As of 10/31/2025 (Updated Monthly)
Number of Issuers
- Fund
- 39
Portfolio Statistics
As of 10/31/2025 (Updated Monthly)
Price to Book
- Fund
- 5.10x
- Fund
- 20.02x
- Fund
- $273.04 Billion
Sector Allocation
As of 10/31/2025 % of Total (Updated Monthly)
| Sector | % of Total | Benchmark |
|---|---|---|
Pharmaceuticals | 39.40% | 41.96% |
Biotechnology | 21.06% | 15.52% |
Health Care Equipment | 14.52% | 17.00% |
Managed Health Care | 6.49% | 5.83% |
Life Sciences Tools & Services | 5.25% | 8.12% |
Health Care Distributors | 4.92% | 2.89% |
Health Care Services | 3.20% | 3.34% |
Health Care Facilities | 1.75% | 1.26% |
Health Care Supplies | 1.26% | 3.29% |
Health Care Technology | — | 0.81% |
Cash & Other Net Assets | 2.15% | — |
Holdings
As of 09/30/2025 (Updated Monthly)
ELI LILLY & CO SEDOL 2516152
ABBVIE INC SEDOL B92SR70
UNITEDHEALTH GROUP INC SEDOL 2917766
JOHNSON & JOHNSON SEDOL 2475833
ASTRAZENECA PLC SEDOL 0989529
THERMO FISHER SCIENTIFIC INC SEDOL 2886907
NOVARTIS AG-REG SEDOL 7103065
BOSTON SCIENTIFIC CORP SEDOL 2113434
ABBOTT LABORATORIES SEDOL 2002305
MCKESSON CORP SEDOL 2378534
Distributions & Tax
- Distribution Frequency
- AnnuallyThis fund is an ex-Dividend fund
- Capital Gain Distributions
- December
Final composition of the current year’s distribution—income, capital gains and/or return of capital—are based on US tax rules and will be determined by February of the following year. For tax characterization of a distribution, such as return of capital and tax-exempt income, click on the “Tax Information” tab above.
Distributions Per Share
12/22/2025
Pricing
Documents
Fund Literature
| Name | Download | Add to Cart | |
|---|---|---|---|
| Factsheet - Putnam Global Health Care Fund |
Regulatory Documents
| Name | Download | Add to Cart | |
|---|---|---|---|
| Annual Report - Putnam Global Health Care Fund - Class Y | |||
| Annual Financial Statements and Other Information - Putnam Global Health Care Fund | |||
| Semi-Annual Report - Putnam Global Health Care Fund - Class Y | |||
| Semi-Annual Financial Statements and Other Information - Putnam Global Health Care Fund | |||
| Prospectus - Putnam Global Health Care Fund | |||
| Summary Prospectus - Putnam Global Health Care Fund | |||
| Statement Of Additional Information - Putnam Global Health Care Fund | |||
| Policy and Procedures - Putnam Global Health Care Fund | |||
| Fiscal Q1 Holdings - Putnam Global Health Care Fund | |||
| Fiscal Q3 Holdings - Putnam Global Health Care Fund |
Risks
All investments involve risks, including possible loss of principal. International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets. Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks. The investment style may become out of favor, which may have a negative impact on performance. To the extent the portfolio invests in a concentration of certain securities, regions or industries, it is subject to increased volatility. The portfolio is non-diversified and may invest in a relatively small number of issuers, which may negatively impact the performance and result in greater fluctuation in value. Derivative instruments can be illiquid, may disproportionately increase losses, and have a potentially large impact on performance. Active management does not ensure gains or protect against market declines. The manager may consider environmental, social and governance (ESG) criteria in the research or investment process; however, ESG considerations may not be a determinative factor in security selection. In addition, the manager may not assess every investment for ESG criteria, and not every ESG factor may be identified or evaluated. These and other risks are discussed in the fund's prospectus.
Important Information
Most funds offer multiple share classes. Share classes are subject to different fees and expenses, which will affect their performance.
Certain share classes are only offered to eligible investors as stated in the prospectus. Different minimums may apply to clients of certain service agents. All classes of shares are not available through all distribution channels. See the Fund's prospectus for additional information.
You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.
Important data provider notices and terms available at www.franklintempletondatasources.com.
Performance data quoted represents past performance, which does not guarantee future results.
CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.
Indexes are unmanaged and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges.
The MSCI World Health Care Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets in the health care sector. Source: MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI.
Net Returns (NR) include income net of tax withholding when dividends are paid.
Investors should carefully consider a fund's investment goals, risks, sales charges and expenses before investing. The prospectus contains this and other information. Please read the prospectus carefully before investing or sending money.
Putnam funds are not exchangeable for other funds distributed by Franklin Distributors, LLC.
Franklin Distributors, LLC. Member FINRA/SIPC. Putnam Investment is a Franklin Templeton company. Investment Products: NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE.
Reports and other information about the funds are available on the EDGAR Database on the SEC's Internet site at www.sec.gov.